Quintis Class Action

Bannister Law has launched a class action against Quintis Ltd (ACN 092 200 854) on behalf of shareholders, who may be eligible for compensation.

It has been reported that Quintis lost a contract supplying Galderma on 16 December 2016, but only disclosed that fact to the ASX over 4 months later, on 10 May 2017. Shares fell 44% on the announcement.

Bannister Law is alleging that Quintis was in breach of its continuous disclosure obligations in only announcing the information to the ASX on 10 May 2017.

If you currently or have previously held shares in Quintis you may be eligible for compensation, and should immediately register for news and updates: http://www.quintisclassaction.com.au/register/